| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Adam H. Zaeske is Chief Commercial Officer at HRMY. Adam H. Zaeske's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $160K at current prices.
Adam H. Zaeske has 3 Form 4 filings on record from April 2025 to April 2026, all as Chief Commercial Officer at Harmony Biosciences (HRMY), 2025–2026.
The 6 reported transactions were 4 option or other derivative awards, 1 option exercise and 1 tax withholding.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria